Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Gross margin
MiniMed Group, Inc.'s gross margin over the twelve months to 31 July 2026 was 53.6%, down 0.6 percentage points from fiscal 2026 (54.2%). That is in line with the Medical Instruments & Supplies industry median of 53.6% and in line with the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 54.2% | (2.12) |
| FY2025 | 56.3% | (1.92) |
| FY2024 | 58.2% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jul 2026 | 55.2% | 9.34 |
| Jan 2026 | 45.8% | (10.75) |
| Jul 2025 | 56.6% | (0.93) |
| Jan 2025 | 57.5% | — |
Gross margin against peers
| Company | Gross margin |
|---|---|
| ATRC AtriCure, Inc. compare | 76.7% |
| BLCO Bausch + Lomb Corporation compare | 62.6% |
| NVST Envista Holdings Corporation compare | 55.9% |
| TFX Teleflex Incorporated compare | 54.9% |
| MMED MiniMed Group, Inc. | 53.6% |
| MMSI Merit Medical Systems, Inc. compare | 49.4% |
| ICUI ICU Medical, Inc. compare | 40.3% |
| STVN Stevanato Group S.p.A. compare | 29.1% |
| PLSE Pulse Biosciences, Inc compare | 26.8% |
| Medical Instruments & Supplies industry median | 53.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement